Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology

Area of Science:

• Neuroscience
• Genetics
• Metabolic Disorders

Background:

• Apolipoprotein E (APOE) ε4 allele and type 2 diabetes mellitus (T2DM) are significant risk factors for Alzheimer's disease (AD).
• The interaction mechanism between T2DM and apoE4 in AD pathogenesis remains unclear.
• Understanding this interplay is crucial for developing targeted AD therapies.

Purpose of the Study:

• To investigate diabetic mechanisms underlying apoE4 pathology in Alzheimer's disease.
• To differentiate peripheral and central nervous system contributions to apoE4-associated AD.
• To explore the impact of diet-induced insulin resistance on apoE4 and apoE3 genotypes.

Main Methods:

• Utilized APOE-targeted replacement mice and high-fat diet (HFD)-induced insulin resistance model.
• Assessed glucose and insulin tolerance, insulin secretion, cognitive, and sensorimotor functions.
• Analyzed peripheral nerve integrity (sciatic electrophysiology, intra-epidermal nerve fiber density) and central nervous system markers (hippocampal insulin receptor, GSK-3β, Akt activation, brain apoE levels).

Main Results:

• APOE ε4 mice exhibited impaired glucose/insulin tolerance and cognitive/sensorimotor deficits under basal conditions compared to APOE ε3 mice.
• HFD exacerbated deficits in APOE ε3 mice but did not significantly affect APOE ε4 mice.
• Peripheral nerve measurements were unaffected, indicating central nervous system involvement. HFD reduced brain apoE levels in APOE ε3 mice to levels similar to APOE ε4 mice.

Conclusions:

• Diabetic mechanisms significantly mediate the pathological effects of APOE ε4.
• Decreased brain apoE levels, influenced by diet, are linked to pathological outcomes in both APOE ε4 and HFD-fed APOE ε3 mice.
• Diabetic therapies may offer a potential treatment strategy for APOE ε4-associated Alzheimer's disease pathology.